FT Weekend: A new weight-loss drug works. Is ...

Before the 2026 midterms, Timothy Garton Ash, emeritus professor of European studies at the University of Oxford and author of ‘Europe in 7½ Chapters’, described the elections as a crucial test of US democracy. Now, with the Democrats’ sweeping victory, could the tide be turning ...  Show more

Jensen Huang has resigned as Nvidia CEO. We look at what it means for the company, AI sector, stock market and the US government’s relationship with China. Plus, European leaders reject Vladimir Putin’s push to overhaul the continent’s security architecture as part of Ukraine pea ...  Show more

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Show more

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more